BRIEF published on 11/12/2024 at 09:06, 9 days 4 hours ago NuWays AG Recommends Buy for DEMIRE AG Following Successful Refinancing DEMIRE AG Refinancing NuWays AG Investment Rating Bond Redemption
PRESS RELEASE published on 11/12/2024 at 09:01, 9 days 4 hours ago Original-Research: DEMIRE AG (von NuWays AG): Buy DEMIRE AG successfully finalizes refinancing, repaying € 245.3m of its corporate bond. Moody's upgrades bond rating to Caa2. Stock undervalued with 73% NAV discount. Reiterate BUY with PT of €1.50 based on NAV Buy Recommendation DEMIRE AG Refinancing Moody's Stock Undervalued
BRIEF published on 11/11/2024 at 07:35, 10 days 5 hours ago DEMIRE Concludes Bond Extension and Resumes Trading DEMIRE AG Corporate Bond Luxembourg Stock Exchange Bond Extension Repurchase And Cancellation
PRESS RELEASE published on 11/11/2024 at 07:30, 10 days 5 hours ago DEMIRE: Successful conclusion of the bond extension until the end of 2027 - Stock exchange trading of the bond resumed DEMIRE Deutsche Mittelstand Real Estate AG successfully extends bond until 2027. Resumed trading on Luxembourg Stock Exchange. Repurchase of EUR 195.4 million bonds Trading Repurchase DEMIRE Bond Extension EUR 195.4 Million
BRIEF published on 11/08/2024 at 09:12, 13 days 4 hours ago NuWays AG Recommends Buy for DEMIRE AG Amid Portfolio Adjustments Real Estate DEMIRE AG NuWays AG Rental Income Asset Disposal
PRESS RELEASE published on 11/08/2024 at 09:07, 13 days 4 hours ago Original-Research: DEMIRE AG (von NuWays AG): Buy NuWays AG's research shows DEMIRE AG's Q3 rental income decline of 20% yoy due to asset base reduction and increased vacancy rate, despite strong letting performance and 12% FFO decrease DEMIRE AG NuWays AG Rental Income Vacancy Rate Asset Base Reduction
BRIEF published on 11/07/2024 at 07:35, 14 days 5 hours ago DEMIRE's 9M 2024 Results Impacted by Smaller Portfolio Financial Results Real Estate 2024 Guidance DEMIRE Portfolio Reduction
PRESS RELEASE published on 11/07/2024 at 07:30, 14 days 5 hours ago DEMIRE achieves lower 9M 2024 result due to smaller portfolio base DEMIRE reports lower 9M 2024 results with reduced rental income and FFO I, net LTV falls to 52.3% after property sales. Guidance for 2024 confirmed Rental Income Guidance DEMIRE FFO I Net LTV
BRIEF published on 10/11/2024 at 09:07, 1 month 10 days ago NuWays AG Upgrades DEMIRE AG to 'Buy' After Bond Prolongation Real Estate DEMIRE AG NuWays AG Investment Rating Corporate Bond
PRESS RELEASE published on 10/11/2024 at 09:02, 1 month 10 days ago Original-Research: DEMIRE AG (von NuWays AG): Buy NuWays AG upgrades DEMIRE AG to Buy with a target price of EUR 1.50 after successful refinancing and clearance for prolongation of corporate bond. Analysis of FY '23, Q1 and Q2 '24 reports provided DEMIRE AG Refinancing NuWays AG Target Price Corporate Bond
Published on 11/21/2024 at 13:00, 27 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 27 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 27 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 27 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 27 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 52 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 12 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 29 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 7 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 42 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 42 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
